These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


149 related items for PubMed ID: 307737

  • 21. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V.
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [Abstract] [Full Text] [Related]

  • 22. Clinical course of patients with anti-RNP antibodies. A prospective study of 32 patients.
    Lundberg I, Hedfors E.
    J Rheumatol; 1991 Oct; 18(10):1511-9. PubMed ID: 1765975
    [Abstract] [Full Text] [Related]

  • 23. [Sharp's syndrome. Clinical, immunological and nosographic aspects].
    Scagliusi P, Muratore M, Martiradonna A, Berlingerio G, Carrozzo M.
    Minerva Med; 1980 Dec 15; 71(50):3655-63. PubMed ID: 6161325
    [Abstract] [Full Text] [Related]

  • 24. [Detection of antibodies to extractable nuclear antigens with counterimmunoelectrophoresis and the Western blot technic].
    Hauke G, Lührmann R, Metz B, Peter HH.
    Z Rheumatol; 1988 Dec 15; 47(1):26-9. PubMed ID: 3259356
    [Abstract] [Full Text] [Related]

  • 25. [A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren's syndrome].
    Akiyama Y, Suzuki T, Tanaka M, Kobayashi K, Kagiri T, Ishibashi T, Kitagawa H, Imai F, Hara K, Doi Y.
    Arerugi; 1990 Jun 15; 39(6):542-7. PubMed ID: 2222196
    [Abstract] [Full Text] [Related]

  • 26. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
    Arad-Dann H, Isenberg DA, Shoenfeld Y, Offen D, Sperling J, Sperling R.
    J Immunol; 1987 Apr 15; 138(8):2463-8. PubMed ID: 3494067
    [Abstract] [Full Text] [Related]

  • 27. Antibody to extractable nuclear antigen in the rheumatic diseases.
    McCain GA, Bell DA, Chodirker WB, Komar RR.
    J Rheumatol; 1978 Apr 15; 5(4):399-406. PubMed ID: 310883
    [Abstract] [Full Text] [Related]

  • 28. Mixed connective tissue disease syndrome.
    Gilliam JN, Prystowsky SD.
    Arch Dermatol; 1977 May 15; 113(5):583-7. PubMed ID: 67824
    [Abstract] [Full Text] [Related]

  • 29. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O, Haïm T.
    Nouv Presse Med; 1982 Oct 09; 11(39):2891-4. PubMed ID: 6755388
    [Abstract] [Full Text] [Related]

  • 30. Anti-Sm and anti-RNP antibodies.
    Migliorini P, Baldini C, Rocchi V, Bombardieri S.
    Autoimmunity; 2005 Feb 09; 38(1):47-54. PubMed ID: 15804705
    [Abstract] [Full Text] [Related]

  • 31. Cold-reactive lymphocytotoxic antibodies in mixed connective tissue disease.
    Diaz-Jouanen E, Llorente L, Ramos-Niembro F, Alarcon-Segovia D.
    J Rheumatol; 1977 Feb 09; 4(1):4-10. PubMed ID: 301941
    [Abstract] [Full Text] [Related]

  • 32. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P, Barrett D, Champlin E.
    Ann Allergy; 1982 Sep 09; 49(3):152-5. PubMed ID: 6981365
    [Abstract] [Full Text] [Related]

  • 33. [Evolution of connective tissue diseases with anti-ribonucleoprotein antibodies (in 28 patients) (author's transl)].
    Benhamou CL, Amor B, Menkes CJ, Delbarre F.
    Ann Med Interne (Paris); 1982 Sep 09; 133(2):72-9. PubMed ID: 6979281
    [Abstract] [Full Text] [Related]

  • 34. Frequency and clinical significance of anti-RNP antibodies in Italian SLE patients.
    Montecucco C, Caporali R, Ravelli A, Ronchetti A, Rossi S, Martini A, Notario A.
    Ann Ital Med Int; 1994 Sep 09; 9(1):12-5. PubMed ID: 8003386
    [Abstract] [Full Text] [Related]

  • 35. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
    Ikeda K, Takasaki Y, Hirokawa K, Takeuchi K, Hashimoto H.
    J Rheumatol; 2003 May 09; 30(5):998-1005. PubMed ID: 12734895
    [Abstract] [Full Text] [Related]

  • 36. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ, de Rooij DJ, Salden MH, Verhagen AP, van Eekelen CA, van de Putte LB, van Venrooij WJ.
    Clin Exp Immunol; 1983 Oct 09; 54(1):265-76. PubMed ID: 6352106
    [Abstract] [Full Text] [Related]

  • 37. [Sharp's syndrome (mixed connective tissue disease). Clinical aspects diagnosis and prognosis].
    Rosenthal M, Müller W.
    Schweiz Med Wochenschr; 1977 Aug 20; 107(33):1162-5. PubMed ID: 197598
    [Abstract] [Full Text] [Related]

  • 38. Clinical and laboratory characteristics of patients with speckled pattern antinuclear antibodies.
    McMillan SA, Fay AC, Taggart AJ, McCrea JD, Roberts SD, Boyd MW, Nelson JK, Haire M.
    Ulster Med J; 1986 Oct 20; 55(2):112-7. PubMed ID: 3492803
    [Abstract] [Full Text] [Related]

  • 39. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
    Agarwal S, Harper J, Kiely PD.
    Lupus; 2009 Apr 20; 18(5):407-12. PubMed ID: 19318392
    [Abstract] [Full Text] [Related]

  • 40. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
    Weill BJ, Job-Deslandre C, Menkès CJ, Amor B.
    Rev Rhum Mal Osteoartic; 1987 Jun 20; 54(6):453-6. PubMed ID: 3303286
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.